Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (181-190 of 270) with videos related to

Pageof 27
Sort By:
Nature Communications|January 26, 2019
IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signalingXia Sheng, Hatice Zeynep Nenseth, Su Qu, et al.
Cancer Research|May 19, 2007
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancerElahe A Mostaghel, Stephanie T Page, Daniel W Lin, et al.
Nature Medicine|November 9, 2010
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceHiroshi Tanaka, Evelyn Kono, Chau P Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Oncotarget|May 28, 2015
Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contactsMarco Trerotola, Kirat K Ganguly, Ladan Fazli, et al.
Oncotarget|October 30, 2015
Erratum: Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contactsMarco Trerotola, Kirat K Ganguly, Ladan Fazli, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancerShan Wang, Rahul K Kollipara, Nishi Srivastava, et al.
Oncogene|October 29, 2025
Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivityChaïma Cherif, Dang Tan Nguyen, Clément Paris, et al.
Oncogene|October 29, 2021
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivityChaïma Cherif, Dang Tan Nguyen, Clément Paris, et al.
Neoplasia (New York, N.Y.)|October 27, 2021
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activationZheng Wang, Mohit Hulsurkar, Lijuan Zhuo, et al.
Pageof 27

Showing results (181-190 of 270) with videos related to

Sort By:
Pageof 27
Nature Communications|January 26, 2019
IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signalingXia Sheng, Hatice Zeynep Nenseth, Su Qu, et al.
Cancer Research|May 19, 2007
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancerElahe A Mostaghel, Stephanie T Page, Daniel W Lin, et al.
Nature Medicine|November 9, 2010
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceHiroshi Tanaka, Evelyn Kono, Chau P Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Oncotarget|May 28, 2015
Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contactsMarco Trerotola, Kirat K Ganguly, Ladan Fazli, et al.
Oncotarget|October 30, 2015
Erratum: Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contactsMarco Trerotola, Kirat K Ganguly, Ladan Fazli, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancerShan Wang, Rahul K Kollipara, Nishi Srivastava, et al.
Oncogene|October 29, 2025
Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivityChaïma Cherif, Dang Tan Nguyen, Clément Paris, et al.
Oncogene|October 29, 2021
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivityChaïma Cherif, Dang Tan Nguyen, Clément Paris, et al.
Neoplasia (New York, N.Y.)|October 27, 2021
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activationZheng Wang, Mohit Hulsurkar, Lijuan Zhuo, et al.
Pageof 27